Saccovid Uses, Dosage, Side Effects and more
Saccovid is a biological immunomodulator originally developed to address graft-versus-host disease in stem cell transplantation in leukemia patients.
| Attribute | Details |
|---|---|
| Trade Name | Saccovid |
| Generic | CD24Fc |
| CD24Fc Other Names | Human CD24 and human IgG Fc Fusion Protein |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Saccovid works
Saccovid is a biological immunomodulator originally developed to address graft-versus-host disease in stem cell transplantation in leukemia patients. It has protective abilities against inflammatory mediators and potential to reduce lung pathology associated with pneumonia. The specific mechanisms by which Saccovid works is currently unknown.
